Orthogonal Light‐ and Enzyme‐Triggered and‐Gate Prodrugs for Senolytic Therapy
Mengyang Chang, Kaixue Zhang, Junwei Wang, Fangchao Bi, Zhuoxin Dai, Miao Yang, Ming Liu, Huanzhi Peng, Franklin Zhang, Yuan Guo, Jigang Dai, Quanxing Liu, Wei Wang · 2026
Read Orthogonal Light‐ and Enzyme‐Triggered and‐Gate Prodrugs for Senolytic Therapy by Mengyang Chang, Kaixue Zhang, Junwei Wang, Fangchao Bi, Zhuoxin Dai, Miao Yang, Ming Liu, Huanzhi Peng, Franklin Zhang, Yuan Guo, Jigang Dai, Quanxing Liu, Wei Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13634484.txt.
Description
Mengyang Chang and twelve co-authors built drugs that attack aged, senescent cells only when two keys turn at once. Drugs aimed at these worn-out cells usually key on an enzyme the cells overproduce, but healthy tissues use it too. The team's design adds a light-sensitive cage over the drug's trigger. Only ultraviolet light can remove the cage, and only then can the enzyme free the payload.
They tested the idea with a glowing probe, a chemotherapy prodrug, and a protein-degrading drug. In several models of senescence, the gated versions killed aged cells more selectively than their always-on parents. In organoids grown from a patient's lung cancer, drug plus light killed tissue that neither treatment touched alone. The work is a proof of concept in dishes and organoids, not yet in animals.
Catalog record
| CREATOR | Mengyang Chang, Kaixue Zhang, Junwei Wang, Fangchao Bi, Zhuoxin Dai, Miao Yang, Ming Liu, Huanzhi Peng, Franklin Zhang, Yuan Guo, Jigang Dai, Quanxing Liu, Wei Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |